Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Probiotics in the Treatment of Irritable Bowel Syndrome in General Practice: A Real-World Narrative Review

Version 1 : Received: 29 February 2024 / Approved: 6 March 2024 / Online: 6 March 2024 (04:45:49 CET)

How to cite: Ferrarini, F.; Milazzo, G. Probiotics in the Treatment of Irritable Bowel Syndrome in General Practice: A Real-World Narrative Review. Preprints 2024, 2024030312. https://doi.org/10.20944/preprints202403.0312.v1 Ferrarini, F.; Milazzo, G. Probiotics in the Treatment of Irritable Bowel Syndrome in General Practice: A Real-World Narrative Review. Preprints 2024, 2024030312. https://doi.org/10.20944/preprints202403.0312.v1

Abstract

Background Although the management of the majority of patients with IBS is dealt with by General Practitioners, randomized clinical trials and treatment guidelines are developed mostly in academic settings. Probiotics are one of the most investigated treatment modality for this condition. Scarce information is available as regards GPs attitude in this regard. Methods A literature search was performed to identify papers specifically dealing with probiotic treatment of IBS in the general practice setting. Moreover, the preliminary results of a survey on this topic conducted by the authors among general practitioners in a province in northern Italy are reported. Results Five papers specifically addressing probiotic treatment of IBS in general practice were found. The response rate varied from 4 to 100%. The prescription rate of probiotics by GPs in IBS varied from <10 to 46%, regardless of the patients’ bowel habits. Physicians’ satisfaction with this treatment varied from 20 to 93%. The variability of these results probably depends on factors such as differences in the interpretation of the available data on probiotics use in IBS and traditional/ cultural differences. Moreover, compliance with patient satisfaction, may play a role. Conclusions The reported data on the treatment of IBS with probiotics in general practice is scarce and inhomogeneous, thus it does not allow firm conclusions. It is suggested that the involvement in research on the use of probiotics in IBS of physicians working in general practice would be useful in order to pursue more reliable and useful results, since the majority of the IBS population is followed in general practice and may differ from the one represented in academic clinical trials.

Keywords

Irritable Bowel Syndrome; Probiotics; General Practice

Subject

Medicine and Pharmacology, Gastroenterology and Hepatology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.